Nikkiso DBB-07 Hemodialysis Machine for Clinical Renal Treatment

The Nikkiso DBB-07 is a hemodialysis machine engineered for reliable and efficient renal replacement therapy in clinical settings. Manufactured in 2013, it supports standard hospital electrical specifications with a voltage range of 220/230/240 V and frequency of 50/60 Hz, consuming 2.3 kVA of power. This device features software version 3.1B with a configurable language setting (originally Italian), allowing adaptability for diverse clinical environments.

Key technical details include:

Widely adopted in bioprocessing and clinical nephrology, the Nikkiso DBB-07 supports critical applications such as biopharmaceutical production pipelines where patient blood purification and fluid management are essential. Its integration into renal therapy labs supports advanced molecular biology research and synthetic biology studies that require precise fluid management systems. The device’s durability and compliance with clinical power standards make it a staple for researchers and medical professionals working on gene editing-related nephrotoxicity studies or live-cell imaging involving biofluid analysis.

This hemodialysis machine is essential for research laboratories focusing on kidney function modeling and treatment optimization and is optimized for professionals seeking reliable clinical-grade equipment for molecular cloning workflows and biomanufacturing environments.